Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary.
What can federal health agencies do to revive the fading trust of the public?
Confidence in public health entities is spiraling downward in the U.S., and once-revered Washington institutions like the CDC and NIH are among the casualties in serious condition. How to break the negative momentum?
Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data
The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.
AAP, other physician societies double down on Kennedy-crossing vaccination stance
5 high-profile physician leaders: ‘Misinformation, politicization of commonsense public health efforts and sudden changes to federal vaccine guidance are creating mass confusion and diminishing trust in public health.’

Predictive model helps identify malignancy in thyroid nodules.

Predictive model uses 6 ultrasound features to differentiate between benign and malignant thyroid nodules

Once the model is further validated, it could help guide providers in determining how to manage thyroid nodules.

Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards

Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial.

Interventional radiologist radiology IR genicular artery embolization surgery

Society of Interventional Radiology joins others in urging Medicare payment for high-cost disposables

The resolution urges the AMA to advocate for separate payment for certain services using supplies priced above $500, as well as those containing high-cost equipment.

Medtronic drug-coated balloon gains multiple new approvals

The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA.

Video interview with Hari Naidu SCAI president on the need for policy for increased radiation protection in the cath lab.

SCAI wants lead-free cath labs and a better work-life balance for cardiologists

"The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview.

Topaz transcatheter tricuspid valve replacement (TTVR) system TriCares

Cardiologist shares positive first-in-human data on TriCares TTVR device

The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure.

Report: UnitedHealth rewarded nursing homes for delaying hospital transfers

Citing evidence from documents and interviews, the Guardian released an exposé accusing UnitedHealth of directly influencing the day-to-day operations of some 2,000 nursing homes, resulting in patients not receiving necessary emergency care.

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

FDA wants new heart damage warnings added to COVID-19 vaccines

COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.

Clinical

Private equity firm jumps into vascular health with new investment

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving

What can federal health agencies do to revive the fading trust of the public?

Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data

AAP, other physician societies double down on Kennedy-crossing vaccination stance